Published in Blood Weekly, October 27th, 1997
These adhesives are not available commercially in the U.S., however, because the U.S. Food and Drug Administration (FDA) has been concerned about the risk that these adhesives, which are formed from plasma collected from hundreds of donors, might spread viral diseases such as hepatitis or AIDS, according to William D. Spotnitz, MD, FACS.
Dr. Spotnitz, professor of surgery and director of the Tissue Adhesive Center at the University of Virginia...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.